▲ Peaking
Health
New pancreatic cancer drug halts tumour growth in 90% of patients
A new combination therapy pairing daraxonrasib with chemotherapy shows striking tumour response in metastatic pancreatic cancer, with one patient's tumours disappearing entirely.